See also this year's filing and all EDGAR filings for this company.
PDF Report 0001509190_2017_ARATANA_THERAPEUTICS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001509190')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001509190, ARATANA THERAPEUTICS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,542,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 47,021,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,948,000 |
| 3 | remainder_Assets | 895,000 |
| 4 | LiabilitiesCurrent | 34,688,000 |
| 5 | LiabilitiesNoncurrent | 540,000 |
| 6 | remainder_Liabilities | 25,775,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,342,000 |
| 9 | ResearchAndDevelopmentExpense | 30,462,000 |
| 10 | remainder_Expenses | 11,566,000 |
| 11 | remainder_Revenues | 38,551,000 |
| 12 | remainder_NetIncome | -2,756,000 |
| 13 | remainder_ComprehensiveNetIncome | -542,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 151,406,000 |
| 1 | Liabilities | 61,003,000 |
| 2 | Expenses | 69,370,000 |
| 3 | Revenues | 38,551,000 |
| 4 | StockholdersEquity | 90,403,000 |
| 5 | NetIncome | -33,575,000 |
| 6 | ComprehensiveNetIncome | -33,846,000 |
| 7 | BaseVar | 161,814,000 |
| 8 | EconomicCapitalRatio | 1.15 |